arjo Alpha Active 3 Manuel D'utilisation page 10

2. Clinical Applications
Indications
Contraindications
Cautions
1. NPUAP/EPUAP International Pressure Ulcer Guideline, 2014.
The Alpha Active 3 system is indicated for the prevention and/or
management of all categories
with an individualised, comprehensive pressure ulcer protocol:
for example, repositioning, nutritional support, skin care.
Selection should be based upon a holistic assessment of the
patient's individual care needs.
The systems represent one aspect of a pressure ulcer
management protocol; all other aspects of care should be
considered by the prescribing clinician.
If existing wounds do not improve or the patient's condition
changes the overall therapy regimen should be reviewed by the
prescribing clinician.
The above are guidelines only and should not replace clinical
judgement.
The Alpha Active 3 mattress is designed for patients weighing up
.
to 135 kg (297 lb)
Do not use Alpha Active 3 system for patients with unstable
spinal fractures.
If patients have other unstable fractures, or conditions which may
be complicated by a soft or moving surface, advice should be
sought from an appropriate clinician before use.
While the Alpha Active 3 system has been designed to manage
patients up to the weight limits indicated above, those
approaching this upper limit are likely to have additional care and
mobility needs and may be better suited to a specialist bariatric
system.
NOTE
The above are guidelines only and should not replace clinical
judgement or experience.
4
1
of pressure ulcer, when combined